Why the study?
Does surgical management (triple valve replacement or combined replacement with annuloplasty) improve survival and functional capacity in patients with triple valve disease?
Population
34 consecutive patients with triple valve disease, 94% in NYHA functional class III or IV before surgery.
Design
Case_series
Follow-up
average 4.4 years
Authors
Loading...
High early mortality warrants cautious patient selection for triple valve surgery; hypothesis-generating from Level 5 data and requires controlled trials.
Does surgical management (triple valve replacement or combined replacement with annuloplasty) improve survival and functional capacity in patients with triple valve disease?
Surgical management of triple valve disease provides significant functional improvement and a 75% 5-year survival rate, though associated with approximately 20% early mortality.
Péterffy et al. (1979) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: